<p>Mice were inoculated 2 times i.n. or i.m. with IDLV-NP, 4 weeks apart. Mice that received either PBS or IDLV-GFP 1 or 2 times i.n. served as a negative control. Serum was collected from each mouse prior to the first immunization, prior to the second immunization (1X), and 4 weeks after the second immunization (2X). NP-specific IgG in serially-diluted serum samples was measured by indirect ELISA assay and is expressed as endpoint titers, defined using the pre-immunization sera as a baseline. Each dot in the panel represents one mouse, and bold lines indicate the mean. The lower limit of detection is indicated by the dotted line. The Kruskal-Wallis test was used to compare antibody titers between the groups (overall p-value of <0.0001). P-...
<p>NiV-specific antibody levels of serum samples from mice immunized subcutaneously three times were...
<p>Mice were administered PBS (control), soluble Ova, or 20 nm NP-Ova p.o. at day 0, 3, 6 and 8, the...
<p>VA387 VLPs, P particles, P dimers were administrated to the mice (30 µg/mouse, n = 5) intranasall...
<p>CDH17<sup>-/-</sup> mice and their WT littermates received a primary immunization with NP-CGG in ...
<p>WT and Fyn KO mice (n = 5–9) were immunized i.p. with 10 ìg of NP-KLH emulsified in 4 mg of Alum...
<p>Groups of BALB/c mice (n = 3) were immunized i.m. with varying doses (TU/mouse) of IDLV-GFP, as i...
<p>Groups of mice (n = 4) were immunized 1 or 2 times, 4 weeks apart, with IDLV-NP via either the i....
<p>Mice were immunized vaginally with 20 nm NP-Ova or PBS (control), then s.c. boosted with 300 µg O...
<p>Anti-NP IgG titers were determined by ELISA on day 60. BALB/c mice (n = 5) were vaccinated with t...
<p>Groups of mice (n = 3) were inoculated with IDLV-NP 2 times i.n. or i.m., 4 weeks apart. Mice (n ...
<p>(A) Immunization regimen for evaluation of route of administration. ELISA plates were coated with...
<p><b>(A)</b> and <b>(B)</b>. Mice were vaccinated with Id-SA, Id-PVP, PVP alone or Id-CP DNA at day...
<p>Groups of 10 female BALB/c mice were inoculated either i.n. or i.p. with NiNLP. As a positive con...
<p>(A) OMV-specific IgGs in BALF were detected in mice that were passively immunized with antiserum;...
<p>BALB/c mice were administered AcHERV-triHPV or PBS (control) three times over a 2-week interval v...
<p>NiV-specific antibody levels of serum samples from mice immunized subcutaneously three times were...
<p>Mice were administered PBS (control), soluble Ova, or 20 nm NP-Ova p.o. at day 0, 3, 6 and 8, the...
<p>VA387 VLPs, P particles, P dimers were administrated to the mice (30 µg/mouse, n = 5) intranasall...
<p>CDH17<sup>-/-</sup> mice and their WT littermates received a primary immunization with NP-CGG in ...
<p>WT and Fyn KO mice (n = 5–9) were immunized i.p. with 10 ìg of NP-KLH emulsified in 4 mg of Alum...
<p>Groups of BALB/c mice (n = 3) were immunized i.m. with varying doses (TU/mouse) of IDLV-GFP, as i...
<p>Groups of mice (n = 4) were immunized 1 or 2 times, 4 weeks apart, with IDLV-NP via either the i....
<p>Mice were immunized vaginally with 20 nm NP-Ova or PBS (control), then s.c. boosted with 300 µg O...
<p>Anti-NP IgG titers were determined by ELISA on day 60. BALB/c mice (n = 5) were vaccinated with t...
<p>Groups of mice (n = 3) were inoculated with IDLV-NP 2 times i.n. or i.m., 4 weeks apart. Mice (n ...
<p>(A) Immunization regimen for evaluation of route of administration. ELISA plates were coated with...
<p><b>(A)</b> and <b>(B)</b>. Mice were vaccinated with Id-SA, Id-PVP, PVP alone or Id-CP DNA at day...
<p>Groups of 10 female BALB/c mice were inoculated either i.n. or i.p. with NiNLP. As a positive con...
<p>(A) OMV-specific IgGs in BALF were detected in mice that were passively immunized with antiserum;...
<p>BALB/c mice were administered AcHERV-triHPV or PBS (control) three times over a 2-week interval v...
<p>NiV-specific antibody levels of serum samples from mice immunized subcutaneously three times were...
<p>Mice were administered PBS (control), soluble Ova, or 20 nm NP-Ova p.o. at day 0, 3, 6 and 8, the...
<p>VA387 VLPs, P particles, P dimers were administrated to the mice (30 µg/mouse, n = 5) intranasall...